Bard Geesaman, M.d., Ph.d.
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
Western States Bank
Norway
Biography
Bard Geesaman, M.D., Ph.D., has been affiliated with MPM and associated portfolio companies since 2002. With broad experience investing, operating and facilitating business development globally, including in Japan, China and Israel, Bard is a Managing Director of MPM’s Oncology Impact Fund (OIF) and serves as Chief Compliance Officer (CCO)
Research Interest
Prior to MPM, Bard founded Catalyst Medical Solutions, a medical documentation and billing eHealth company in Boston where he served as the Chief Technology Officer through the company’s acquisition. After Catalyst, Bard joined Centagenetix, an MPM-founded company exploring the genetics of successful aging.
